LADQX Lord Abbett Developing Growth R2 Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Guardant Health (NASDAQ:GH).

The investment seeks long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter. The fund invests in equity securities of companies that the portfolio management team believes demonstrate above-average, long-term growth potential. Under normal conditions, the fund invests at least 65% of its net assets in equity securities of small companies. It may invest up to 20% of its net assets in securities of foreign companies, including emerging market companies, ADRs, Global Depositary Receipts (“GDRs”), and other similar depositary receipts.

The average market capitalization across the Lord Abbett Developing Growth R2 MF is 19.27B. The market cap for tickers in the group ranges from 10.75B to 59.51B. FIX holds the highest valuation in this group at 59.51B. The lowest valued company is FROG at 10.75B.

The average weekly volume growth across all stocks in the Lord Abbett Developing Growth R2 MF was -10%. For the same stocks of the MF, the average monthly volume growth was -58% and the average quarterly volume growth was 9%